NHS (Neuberger Berman High Yield Strategies Fund) ROC (Joel Greenblatt) %: % (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NHS Neuberger Berman High Yield Strategies Fund Inc NHS
44 GF Score
Price $6.21
GF Value $7.23
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Neuberger Berman High Yield Strategies Fund ROC (Joel Greenblatt) %?

Neuberger Berman High Yield Strategies Fund NHS +0.16% 44 ROC (Joel Greenblatt) % is % as of Apr. 2026. GuruFocus rates NHS with a GF Score™ of 44/100 and a GF Value™ of $7.23 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 627 Asset Management companies, Neuberger Berman High Yield Strategies Fund ranks worse than 159489.47% on this metric.

ROC (Joel Greenblatt) % does not apply to banks and insurance companies.

NHS
44GF Score
Neuberger Berman High Yield Strategies Fund Inc NHS
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a ROC (Joel Greenblatt) % of % mean?
Neuberger Berman High Yield Strategies Fund (NHS) has a ROC (Joel Greenblatt) % of % as of Apr. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Neuberger Berman High Yield Strategies Fund and its competitors. According to the industry distribution chart, Neuberger Berman High Yield Strategies Fund ranks #999999 out of 627 companies in the Asset Management industry.
Is Neuberger Berman High Yield Strategies Fund's ROC (Joel Greenblatt) % too high?
Neuberger Berman High Yield Strategies Fund's current ROC (Joel Greenblatt) % is %. Based on the distribution chart, Neuberger Berman High Yield Strategies Fund ranks #999999 out of 627 companies in the Asset Management industry, which is in the bottom quartile relative to peers. Overall, Neuberger Berman High Yield Strategies Fund has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neuberger Berman High Yield Strategies Fund's ROC (Joel Greenblatt) % compare to NRO and TPVG?
According to the Asset Management industry distribution chart, Neuberger Berman High Yield Strategies Fund ranks #999999 out of 627 companies for ROC (Joel Greenblatt) %. This places Neuberger Berman High Yield Strategies Fund in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 63.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for an Asset Management company?
The median ROC (Joel Greenblatt) % among Asset Management companies is 63.97, based on 627 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Neuberger Berman High Yield Strategies Fund and its competitors. For the Asset Management industry, the median ROC (Joel Greenblatt) % is 63.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neuberger Berman High Yield Strategies Fund's current ROC (Joel Greenblatt) % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuberger Berman High Yield Strategies Fund stock overvalued right now?
Based on GuruFocus' analysis, Neuberger Berman High Yield Strategies Fund (NHS) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.23, compared to a current price of $6.21 — trading 14.1% below its estimated fair value. The current ROC (Joel Greenblatt) % is %. Neuberger Berman High Yield Strategies Fund's overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Neuberger Berman High Yield Strategies Fund (NHS), the current ROC (Joel Greenblatt) % is % as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neuberger Berman High Yield Strategies Fund (NHS) Overvalued in 2026?

Based on GuruFocus' analysis, Neuberger Berman High Yield Strategies Fund stock appears to be undervalued. The current stock price of $6.21 is trading 14.1% below its estimated GF Value™ of $7.23. GuruFocus considers Neuberger Berman High Yield Strategies Fund to be Modestly Undervalued.

Key valuation signals for NHS:

  • ROC (Joel Greenblatt) %: %
  • GF Value™: $7.23 vs. price of $6.21 (14.1% below fair value)
  • GF Score™: 44/100 with 6 warning signs

No single metric tells the full story. See the NHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Neuberger Berman High Yield Strategies Fund Business Description

Address c/o Neuberger Berman Investment Advisers LLC, 1290 Avenue of the Americas, New York, NY, USA, 10104-0002
Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.
44GF Score

Get the complete analysis for NHS

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.21
Price
$7.23
GF Value